Kymera Therapeutics to Host Virtual Immunology R&D Day on January 4

Company to provide update on its emerging pipeline of high-value immunology programsWATERTOWN, Mass., Dec. 13, 2023 -- Kymera Therapeutics, Inc. , a clinical-stage biopharmaceutical company...

Related Keywords

Watertown ,Massachusetts ,United States ,Boston ,Todd Cooper ,Justine Koenigsberg ,Corporate Affairs ,Nasdaq ,Boston Globe ,Kymera Therapeutics Inc ,Immunology Rd Day ,Fierce Biotech ,Boston Business Journal ,Vice President ,Markets ,